{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:09:57Z","timestamp":1790712597903,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,5,1]],"date-time":"2027-05-01T00:00:00Z","timestamp":1809129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,5,1]],"date-time":"2027-05-01T00:00:00Z","timestamp":1809129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2027,5]]},"DOI":"10.1016\/j.vhri.2026.102131","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:31:33Z","timestamp":1790710293000},"page":"102131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cost-Effectiveness of Peripheral Neuropathy Screening in Patients With Thalassemia: A Hybrid Decision-Markov Model"],"prefix":"10.1016","volume":"59","author":[{"given":"Ai Ch\u2019i","family":"Liew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asrul","family":"Akmal Shafie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Looi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lay Khoon","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vhri.2026.102131_bib1","article-title":"Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT)","author":"Cappellini","year":"2014","journal-title":"Nicosia, Cyprus: Thalassaemia International Federation"},{"issue":"8","key":"10.1016\/j.vhri.2026.102131_bib2","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJMoa1010174","article-title":"Heterogeneity of hemoglobin H disease in childhood","volume":"364","author":"Lal","year":"2011","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vhri.2026.102131_bib3","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00277-015-2378-z","article-title":"Neurological complications of beta-thalassemia","volume":"94","author":"Nemtsas","year":"2015","journal-title":"Ann Hematol"},{"issue":"11","key":"10.1016\/j.vhri.2026.102131_bib4","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/jnnp.54.11.997","article-title":"Peripheral neuropathy in patients with beta-thalassaemia","volume":"54","author":"Papanastasiou","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.vhri.2026.102131_bib5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0887-8994(98)00004-6","article-title":"Neurophysiologic evaluation of long-term desferrioxamine therapy in beta-thalassemia patients","volume":"18","author":"Zafeiriou","year":"1998","journal-title":"Pediatr Neurol"},{"issue":"5","key":"10.1016\/j.vhri.2026.102131_bib6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.5144\/0256-4947.2006.358","article-title":"Peripheral neuropathy in thalassemia","volume":"26","author":"Sawaya","year":"2006","journal-title":"Ann Saudi Med"},{"issue":"10","key":"10.1016\/j.vhri.2026.102131_bib7","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1136\/jnnp.2003.024794","article-title":"Axonal sensorimotor neuropathy in patients with \u03b2-thalassaemia","volume":"75","author":"Stamboulis","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.vhri.2026.102131_bib8","first-page":"159","article-title":"Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2\u2217 MRI in thalassemia maior","volume":"8","author":"Ansari","year":"2017","journal-title":"Caspian J Intern Med"},{"issue":"4","key":"10.1016\/j.vhri.2026.102131_bib9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s12098-018-2797-7","article-title":"Peripheral neuropathy in thalassemia major","volume":"86","author":"Kaushik","year":"2019","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.vhri.2026.102131_bib10","series-title":"Impact on Quality of Life in Peoples With Painful Diabetic Peripheral Neuropathy","author":"Kim","year":"2015"},{"issue":"3","key":"10.1016\/j.vhri.2026.102131_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.diabet.2008.11.004","article-title":"Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics","volume":"35","author":"Van Acker","year":"2009","journal-title":"Diabetes Metab"},{"issue":"2","key":"10.1016\/j.vhri.2026.102131_bib12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.vhri.2026.102131_bib13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jpainsymman.2005.04.009","article-title":"Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep","volume":"30","author":"Gore","year":"2005","journal-title":"J Pain Symptom Manag"},{"issue":"4","key":"10.1016\/j.vhri.2026.102131_bib14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ejpain.2009.07.006","article-title":"Severe chronic pain is associated with increased 10 year mortality. A cohort record linkage study","volume":"14","author":"Torrance","year":"2010","journal-title":"Eur J Pain"},{"key":"10.1016\/j.vhri.2026.102131_bib15","series-title":"Clinical Practice Guidelines Management of Thalassaemia","first-page":"121","year":"2024"},{"issue":"5","key":"10.1016\/j.vhri.2026.102131_bib18","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ana.410210515","article-title":"Reversible and irreversible nodal dysfunction in diabetic neuropathy","volume":"21","author":"Brismar","year":"1987","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.vhri.2026.102131_bib19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1055\/s-0039-1694747","article-title":"A clinician\u2019s approach to peripheral neuropathy","volume":"39","author":"Siao","year":"2019","journal-title":"Semin Neurol"},{"issue":"2","key":"10.1016\/j.vhri.2026.102131_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.15850\/amj.v9n2.2301","article-title":"Dietary intake, Nutritional status, and quality of life in patients with thalassemia major","volume":"9","author":"Usman","year":"2022","journal-title":"Althea Med J"},{"issue":"1-4","key":"10.1016\/j.vhri.2026.102131_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3111\/200609055068","article-title":"The economic burden of neuropathic pain in Canada","volume":"9","author":"Tarride","year":"2006","journal-title":"J Med Econ"},{"key":"10.1016\/j.vhri.2026.102131_bib22","series-title":"Order 2014","first-page":"7","year":"2014"},{"issue":"2","key":"10.1016\/j.vhri.2026.102131_bib23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00400697","article-title":"A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population","volume":"36","author":"Young","year":"1993","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.vhri.2026.102131_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00019053-200725040-00005","article-title":"Cost effectiveness of once-daily oral chelation therapy with deferasirox versus infusional deferoxamine in transfusion-dependent thalassaemia patients: US healthcare system perspective","volume":"25","author":"Delea","year":"2007","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vhri.2026.102131_bib25","series-title":"Pharmacy Information System (PhiS)","year":"2023"},{"key":"10.1016\/j.vhri.2026.102131_bib26","series-title":"Pharmay Information System (PhiS). Electronic database","year":"2023"},{"key":"10.1016\/j.vhri.2026.102131_bib27","series-title":"Annual Report of the Malaysian Thalassaemia Registry","year":"2019"},{"issue":"6","key":"10.1016\/j.vhri.2026.102131_bib28","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1590\/S0004-27302005000600014","article-title":"Translation into Portuguese and assessment of the reliability of a scale for the diagnosis of diabetic distal polyneuropathy","volume":"49","author":"Moreira","year":"2005","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.vhri.2026.102131_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109063","article-title":"Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: international expert consensus recommendations","volume":"186","author":"Ziegler","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.vhri.2026.102131_bib30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jbmt.2023.11.030","article-title":"Behavior of neuropathy symptom score and neuropathy disability score in patients with and without peripheral diabetic neuropathy: a retrospective cohort study","volume":"37","author":"Nogueira","year":"2024","journal-title":"J Bodyw Mov Ther"},{"issue":"2","key":"10.1016\/j.vhri.2026.102131_bib32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s41669-023-00443-w","article-title":"Health state utilities associated with false-positive cancer screening results","volume":"8","author":"Matza","year":"2024","journal-title":"Pharmacoecon Open"},{"key":"10.1016\/j.vhri.2026.102131_bib33","first-page":"1","article-title":"Problems and solutions in calculating quality-adjusted life years (QALYs)","volume":"1","author":"Prieto","year":"2003","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"10.1016\/j.vhri.2026.102131_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldq033","article-title":"Health outcomes in economic evaluation: the QALY and utilities","volume":"96","author":"Whitehead","year":"2010","journal-title":"Br Med Bull"},{"issue":"7","key":"10.1016\/j.vhri.2026.102131_bib35","first-page":"521","article-title":"Better decision making in preventive health screening: balancing benefits and harms","volume":"63","author":"Bell","year":"2017","journal-title":"Can Fam Physician"},{"issue":"9","key":"10.1016\/j.vhri.2026.102131_bib36","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.3324\/haematol.2021.278684","article-title":"Survival and causes of death in 2,033 patients with non-transfusion-dependent \u03b2-thalassemia","volume":"106","author":"Musallam","year":"2021","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.vhri.2026.102131_bib37","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.braindev.2006.02.005","article-title":"Neurological complications in \u03b2-thalassemia","volume":"28","author":"Zafeiriou","year":"2006","journal-title":"Brain Dev"},{"issue":"3","key":"10.1016\/j.vhri.2026.102131_bib38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5339\/qmj.2024.24","article-title":"Using biothesiometer, Neuropathy Symptom Score, and Neuropathy Disability Score for the early detection of peripheral neuropathy: a cross-sectional study","volume":"2024","author":"Mooi","year":"2024","journal-title":"Qatar Med J"},{"key":"10.1016\/j.vhri.2026.102131_bib40","series-title":"Pharmacoeconomic Guidelines for Malaysia","year":"2019"},{"key":"10.1016\/j.vhri.2026.102131_bib41","series-title":"Commisssion on Macroeconomics and Health Macroeconomics and Health: Investing in Health for Economic Development","year":"2001"},{"issue":"5","key":"10.1016\/j.vhri.2026.102131_bib42","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.clinimag.2011.11.019","article-title":"Clinical and imaging findings in thalassemia patients with extramedullary hematopoiesis","volume":"36","author":"Zhu","year":"2012","journal-title":"Clin Imaging"},{"issue":"13","key":"10.1016\/j.vhri.2026.102131_bib43","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.3390\/ijms23137267","article-title":"Iron, neuroinflammation and neurodegeneration","volume":"23","author":"Ward","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.vhri.2026.102131_bib44","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s12288-018-1050-x","article-title":"Polyneuropathy associated with severe iron overload and oxidative stress in \u03b2-thalassemia patients","volume":"35","author":"El-Tagui","year":"2019","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"1","key":"10.1016\/j.vhri.2026.102131_bib45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s43054-024-00257-3","article-title":"Frequency and potential risk factors of polyneuropathy in transfusion-dependent B-thalassemia major patients: a cross-sectional study","volume":"72","author":"Risha","year":"2024","journal-title":"Egypt Pediatric Association Gaz"},{"key":"10.1016\/j.vhri.2026.102131_bib46","series-title":"Alterations of Neuromuscular Environment Are Associated With Chronic Tissue Hypoxia in \u03b2-Thalassemia Patients","author":"Piolatto","year":"2022"},{"issue":"2","key":"10.1016\/j.vhri.2026.102131_bib47","doi-asserted-by":"crossref","DOI":"10.29313\/gmhc.v9i2.8106","article-title":"Relationship between vitamin B9 (folic acid), vitamin B12 (cobalamin), and peripheral neuropathy in children with beta-thalassemia major","volume":"9","author":"Gamayani","year":"2021","journal-title":"Glob Med Health Commun"},{"key":"10.1016\/j.vhri.2026.102131_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111341","article-title":"Deferoxamine-induced neurotoxicity: role of chaperone-mediated autophagy dysfunction in neuronal apoptosis in the hippocampus","volume":"406","author":"Zhang","year":"2025","journal-title":"Chem-Biol Interact"},{"issue":"1","key":"10.1016\/j.vhri.2026.102131_bib49","article-title":"Elevated prevalence of abnormal glucose metabolism and other endocrine disorders in patients with \u03b2-thalassemia major: a meta-analysis","volume":"2019","author":"He","year":"2019","journal-title":"BioMed Res Int"},{"issue":"1","key":"10.1016\/j.vhri.2026.102131_bib50","first-page":"12","article-title":"Prevalence and risk factors of diabetes mellitus in \u03b2-thalassemia major patients in the north of Iran: Mazandaran \u03b2-thalassemia Registry-2017 to 2019","volume":"3","author":"Mortazavi","year":"2021","journal-title":"Tabari Biomed Stu Res J"},{"issue":"36","key":"10.1016\/j.vhri.2026.102131_bib51","first-page":"3423","article-title":"Neurotoxic effects of iron overload under high glucose concentration","volume":"8","author":"Zhao","year":"2013","journal-title":"Neural Regen Res"},{"issue":"2","key":"10.1016\/j.vhri.2026.102131_bib52","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/M20-1340","article-title":"Peripheral neuropathy and all-cause and cardiovascular mortality in US adults: a prospective cohort study","volume":"174","author":"Hicks","year":"2021","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.vhri.2026.102131_bib53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jpain.2003.12.004","article-title":"Clinical characteristics and economic costs of patients with painful neuropathic disorders","volume":"5","author":"Berger","year":"2004","journal-title":"J Pain"},{"key":"10.1016\/j.vhri.2026.102131_bib54","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.vhri.2020.08.003","article-title":"Validity of the Malay EQ-5D-3L in the Malaysian transfusion-dependent thalassemia population","volume":"24","author":"Shafie","year":"2021","journal-title":"Value Health Reg Issues"},{"issue":"4","key":"10.1016\/j.vhri.2026.102131_bib55","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s11136-010-9774-6","article-title":"A cross-sectional validation study of EQ-5D among the Malaysian adult population","volume":"20","author":"Shafie","year":"2011","journal-title":"Qual Life Res"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109926005467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109926005467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:31:41Z","timestamp":1790710301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109926005467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,5]]},"references-count":51,"alternative-id":["S2212109926005467"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2026.102131","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2027,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness of Peripheral Neuropathy Screening in Patients With Thalassemia: A Hybrid Decision-Markov Model","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2026.102131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"102131"}}